Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade

高选择性HPK1抑制剂NDI-101150可介导免疫细胞活化和强大的抗肿瘤反应，这与免疫检查点阻断不同。